Evidence map›Paper›PMID 29487215›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Phosphorylation-dependent activation of the cell wall synthase PBP2a in

Andrew K Fenton, Sylvie Manuse, Josué Flores-Kim, Pierre Simon Garcia, Chryslène Mercy, Christophe Grangeasse, Thomas G Bernhardt, David Z Rudner

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. How do spherical bacteria regulate cell division?Biochemical Society transactions · 2025
    Review
  9. ACS infectious diseases · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Andrew K FentonDepartment of Microbiology and Immunobiology, Harvard Medical School; Boston, MA 02115; a.k.fenton@sheffield.ac.uk c.grangeasse@ibcp.fr thomas_bernhardt@hms.harvard.edu david_rudner@hms.harvard.edu.
Sylvie ManuseMolecular Microbiology and Structural Biochemistry, UMR 5086, CNRS, Université de Lyon, 69367 Lyon, France.
Josué Flores-KimDepartment of Microbiology and Immunobiology, Harvard Medical School; Boston, MA 02115.
Pierre Simon GarciaMolecular Microbiology and Structural Biochemistry, UMR 5086, CNRS, Université de Lyon, 69367 Lyon, France.
Chryslène MercyMolecular Microbiology and Structural Biochemistry, UMR 5086, CNRS, Université de Lyon, 69367 Lyon, France.
Christophe GrangeasseMolecular Microbiology and Structural Biochemistry, UMR 5086, CNRS, Université de Lyon, 69367 Lyon, France a.k.fenton@sheffield.ac.uk c.grangeasse@ibcp.fr thomas_bernhardt@hms.harvard.edu david_rudner@hms.harvard.edu.
Thomas G BernhardtDepartment of Microbiology and Immunobiology, Harvard Medical School; Boston, MA 02115; a.k.fenton@sheffield.ac.uk c.grangeasse@ibcp.fr thomas_bernhardt@hms.harvard.edu david_rudner@hms.harvard.edu.
David Z RudnerDepartment of Microbiology and Immunobiology, Harvard Medical School; Boston, MA 02115; a.k.fenton@sheffield.ac.uk c.grangeasse@ibcp.fr thomas_bernhardt@hms.harvard.edu david_rudner@hms.harvard.edu.
Harvard University · USCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRUniversity of Sheffield · GB

Funding

Targeting bacterial cell wall biogenesis for the development of novel antimicrobU19AI109764 · NIAID · HARVARD MEDICAL SCHOOL · PI KASPER, DENNIS L. · 2014 to 2018
$25.2M
Peptidoglycan Biogenesis in Escherichia ColiR01AI083365 · NIAID · HARVARD MEDICAL SCHOOL · PI Thomas G Bernhardt · 2010 to 2026
$8.3M
Membrane Remodeling and Protein Trafficking in BacteriaR01GM073831 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RUDNER, DAVID Z · 2005 to 2014
$3.4M
NIAID NIH HHS R01 AI083365NIAID NIH HHS U19 AI109764NIGMS NIH HHS R01 GM073831
6 · The paper itself

Abstract

Most bacterial cells are surrounded by an essential cell wall composed of the net-like heteropolymer peptidoglycan (PG). Growth and division of bacteria are intimately linked to the expansion of the PG meshwork and the construction of a cell wall septum that separates the nascent daughter cells. Class A penicillin-binding proteins (aPBPs) are a major family of PG synthases that build the wall matrix. Given their central role in cell wall assembly and importance as drug targets, surprisingly little is known about how the activity of aPBPs is controlled to properly coordinate cell growth and division. Here, we report the identification of MacP (SPD_0876) as a membrane-anchored cofactor of PBP2a, an aPBP synthase of the Gram-positive pathogen

Indexed as

Bacterial ProteinsCell DivisionCell WallCoenzymesGene Expression Regulation, BacterialPenicillin-Binding ProteinsPhosphorylationStreptococcus pneumoniaeBacterial ProteinsCoenzymesmecA protein, Staphylococcus aureusPenicillin-Binding Proteinsbacterial physiologycell divisioncell wallPBPpeptidoglycan

Identifiers

PMID29487215
PMCPMC5856526
OpenAlexW2789805902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.